Related content

The effects of bromocriptine on VEGF, kidney function and ovarian hyperstimulation syndrome in in vitro fertilization patients: a pilot study

By Beltrame Ana Lúcia   Serafini Paulo   Motta Eduardo L. A.   Soares Júnior José Maria   Baracat Edmund C.  

Gynecological Endocrinology, Vol. 29, Iss. 3, 2013-03 ,pp. : 201-204

Informa Healthcare

Access to resources Recommend Favorite

The optimal length of ‘coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization

By Nardo Luciano   Cheema Priya   Gelbaya Tarek   Horne Greg   Fitzgerald Cheryl   Pease Elizabeth   Brison Daniel   Lieberman Brian  

Human Fertility, Vol. 9, Iss. 3, 2006-09 ,pp. : 175-180

Informa Healthcare

Access to resources Recommend Favorite

Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?

By Orvieto Raoul   Meltcer Simion   Liberty Gad   Rabinson Jacob   Anteby Eyal Y.   Nahum Ravit  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 422-424

Informa Healthcare

Access to resources Recommend Favorite

Outcomes from ovarian hyperstimulation following the sole administration of gonadotrophin-releasing hormone agonist in the context of in vitro fertilization: report of two cases and review of the literature

By Pinto Evelin   Pinelo Sueli   Osório Marta   Ferreira Carla   Serra Helena   Pires Ilda   Barbosa António   Figueiredo Helena   Felgueira Eduarda   Tavares Angelina  

Gynecological Endocrinology, Vol. 28, Iss. 7, 2012-07 ,pp. : 545-548

Informa Healthcare

Access to resources Recommend Favorite

Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF)

By Kamble Lata   Gudi Anil   Shah Amit   Homburg Roy  

Human Fertility, Vol. 14, Iss. 4, 2011-12 ,pp. : 230-245

Informa Healthcare

Access to resources Recommend Favorite